Pharmacoequity: Improving Representation in Medicine and Fairness in Care
Access to safe and effective medicines is a cornerstone of modern healthcare. Yet, not everyone enjoys equal benefit from the advancements in pharmaceutical research and innovation. Pharmacoequity is the principle that every individual, regardless of race, ethnicity,...
The Microbiome and Cancer: What Do We Know?
Insights from research and an interview with Dr Jennifer Wargo, MD, University of Texas M.D. Anderson Cancer Center, as featured in a recent JAMA interview. The human body is home to trillions of microbes – bacteria, viruses, fungi, and other microorganisms...
Female Genital Mutilation/Cutting: Understanding the Ongoing Global Crisis
Female genital mutilation (FGM) is defined by the World Health Organization (WHO) as ‘all procedures which intentionally alter or damage the external female genitalia organs for non-medical reasons and which have no benefit for the health of young girls and women.’...
Exploring the Value of Implementation Research: Highlights from the CREDO Webinar
On 28 November, Pharmalys hosted an online webinar titled ‘Implementation Research: What is it about and what is its value?’ as part of the CREDO (Clinical Research Excellence and Development Opportunity) initiative. CREDO, for which Pharmalys serves as the...